ALZCHEM GROUP AG (ACT.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:ACT - DE000A2YNT30 - Common Stock
156 EUR
+1 (+0.65%)
Taking everything into account, ACT scores 7 out of 10 in our fundamental rating. ACT was compared to 71 industry peers in the Chemicals industry. ACT scores excellent points on both the profitability and health parts. This is a solid base for a good stock. While showing a medium growth rate, ACT is valued expensive at the moment. These ratings would make ACT suitable for quality investing!
1. Profitability
1.1 Basic Checks
- In the past year ACT was profitable.
- ACT had a positive operating cash flow in the past year.
- ACT had positive earnings in each of the past 5 years.
- ACT had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
- Looking at the Return On Assets, with a value of 10.49%, ACT belongs to the top of the industry, outperforming 95.65% of the companies in the same industry.
- ACT has a better Return On Equity (26.47%) than 95.65% of its industry peers.
- With an excellent Return On Invested Capital value of 13.45%, ACT belongs to the best of the industry, outperforming 92.75% of the companies in the same industry.
- ACT had an Average Return On Invested Capital over the past 3 years of 12.06%. This is above the industry average of 7.19%.
- The last Return On Invested Capital (13.45%) for ACT is above the 3 year average (12.06%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.49% | ||
| ROE | 26.47% | ||
| ROIC | 13.45% |
ROA(3y)8.81%
ROA(5y)7.86%
ROE(3y)22.87%
ROE(5y)25.91%
ROIC(3y)12.06%
ROIC(5y)10.63%
1.3 Margins
- ACT has a better Profit Margin (10.97%) than 84.06% of its industry peers.
- In the last couple of years the Profit Margin of ACT has grown nicely.
- ACT's Operating Margin of 15.93% is amongst the best of the industry. ACT outperforms 84.06% of its industry peers.
- In the last couple of years the Operating Margin of ACT has grown nicely.
- ACT's Gross Margin of 66.55% is amongst the best of the industry. ACT outperforms 97.10% of its industry peers.
- ACT's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 15.93% | ||
| PM (TTM) | 10.97% | ||
| GM | 66.55% |
OM growth 3Y17.53%
OM growth 5Y12.4%
PM growth 3Y14.29%
PM growth 5Y15.31%
GM growth 3Y2.01%
GM growth 5Y1.44%
2. Health
2.1 Basic Checks
- ACT has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
- ACT has less shares outstanding than it did 1 year ago.
- ACT has less shares outstanding than it did 5 years ago.
- The debt/assets ratio for ACT has been reduced compared to a year ago.
2.2 Solvency
- An Altman-Z score of 5.06 indicates that ACT is not in any danger for bankruptcy at the moment.
- ACT has a Altman-Z score of 5.06. This is amongst the best in the industry. ACT outperforms 88.41% of its industry peers.
- The Debt to FCF ratio of ACT is 1.32, which is an excellent value as it means it would take ACT, only 1.32 years of fcf income to pay off all of its debts.
- Looking at the Debt to FCF ratio, with a value of 1.32, ACT belongs to the top of the industry, outperforming 94.20% of the companies in the same industry.
- A Debt/Equity ratio of 0.16 indicates that ACT is not too dependend on debt financing.
- The Debt to Equity ratio of ACT (0.16) is better than 75.36% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.16 | ||
| Debt/FCF | 1.32 | ||
| Altman-Z | 5.06 |
ROIC/WACC1.85
WACC7.29%
2.3 Liquidity
- ACT has a Current Ratio of 2.87. This indicates that ACT is financially healthy and has no problem in meeting its short term obligations.
- With an excellent Current ratio value of 2.87, ACT belongs to the best of the industry, outperforming 82.61% of the companies in the same industry.
- ACT has a Quick Ratio of 1.77. This is a normal value and indicates that ACT is financially healthy and should not expect problems in meeting its short term obligations.
- Looking at the Quick ratio, with a value of 1.77, ACT belongs to the top of the industry, outperforming 81.16% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.87 | ||
| Quick Ratio | 1.77 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 24.12% over the past year.
- The Earnings Per Share has been growing by 24.60% on average over the past years. This is a very strong growth
- ACT shows a small growth in Revenue. In the last year, the Revenue has grown by 1.05%.
- ACT shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.06% yearly.
EPS 1Y (TTM)24.12%
EPS 3Y25.02%
EPS 5Y24.6%
EPS Q2Q%31.66%
Revenue 1Y (TTM)1.05%
Revenue growth 3Y9.49%
Revenue growth 5Y8.06%
Sales Q2Q%6.46%
3.2 Future
- Based on estimates for the next years, ACT will show a very strong growth in Earnings Per Share. The EPS will grow by 20.26% on average per year.
- ACT is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.02% yearly.
EPS Next Y21.07%
EPS Next 2Y12.7%
EPS Next 3Y18.06%
EPS Next 5Y20.26%
Revenue Next Year2.51%
Revenue Next 2Y5.13%
Revenue Next 3Y8.61%
Revenue Next 5Y6.02%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
- A Price/Earnings ratio of 25.57 indicates a quite expensive valuation of ACT.
- Compared to the rest of the industry, the Price/Earnings ratio of ACT is on the same level as its industry peers.
- The average S&P500 Price/Earnings ratio is at 27.21. ACT is around the same levels.
- The Price/Forward Earnings ratio is 24.11, which indicates a rather expensive current valuation of ACT.
- ACT's Price/Forward Earnings is on the same level as the industry average.
- ACT's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 25.98.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 25.57 | ||
| Fwd PE | 24.11 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, ACT is valued a bit more expensive than the industry average as 60.87% of the companies are valued more cheaply.
- ACT's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 45.39 | ||
| EV/EBITDA | 13.39 |
4.3 Compensation for Growth
- The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
- ACT has an outstanding profitability rating, which may justify a higher PE ratio.
- A more expensive valuation may be justified as ACT's earnings are expected to grow with 18.06% in the coming years.
PEG (NY)1.21
PEG (5Y)1.04
EPS Next 2Y12.7%
EPS Next 3Y18.06%
5. Dividend
5.1 Amount
- With a Yearly Dividend Yield of 1.16%, ACT has a reasonable but not impressive dividend return.
- ACT's Dividend Yield is slightly below the industry average, which is at 2.45.
- Compared to the average S&P500 Dividend Yield of 1.81, ACT is paying slightly less dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.16% |
5.2 History
- The dividend of ACT has a limited annual growth rate of 6.00%.
Dividend Growth(5Y)6%
Div Incr Years5
Div Non Decr Years5
5.3 Sustainability
- 49.16% of the earnings are spent on dividend by ACT. This is a bit on the high side, but may be sustainable.
- ACT's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP49.16%
EPS Next 2Y12.7%
EPS Next 3Y18.06%
ALZCHEM GROUP AG / ACT.DE FAQ
Can you provide the ChartMill fundamental rating for ALZCHEM GROUP AG?
ChartMill assigns a fundamental rating of 7 / 10 to ACT.DE.
What is the valuation status for ACT stock?
ChartMill assigns a valuation rating of 3 / 10 to ALZCHEM GROUP AG (ACT.DE). This can be considered as Overvalued.
Can you provide the profitability details for ALZCHEM GROUP AG?
ALZCHEM GROUP AG (ACT.DE) has a profitability rating of 9 / 10.
Can you provide the financial health for ACT stock?
The financial health rating of ALZCHEM GROUP AG (ACT.DE) is 9 / 10.
What is the earnings growth outlook for ALZCHEM GROUP AG?
The Earnings per Share (EPS) of ALZCHEM GROUP AG (ACT.DE) is expected to grow by 21.07% in the next year.